The Procter & Gamble Company (NYSE:PG) Shares Sold by Blue Fin Capital Inc.

Blue Fin Capital Inc. trimmed its position in The Procter & Gamble Company (NYSE:PGFree Report) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 10,278 shares of the company’s stock after selling 107 shares during the quarter. Blue Fin Capital Inc.’s holdings in Procter & Gamble were worth $1,506,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Sapient Capital LLC acquired a new position in Procter & Gamble in the fourth quarter worth $10,511,000. W Advisors LLC boosted its stake in Procter & Gamble by 3.5% in the fourth quarter. W Advisors LLC now owns 5,633 shares of the company’s stock valued at $825,000 after acquiring an additional 191 shares during the period. Axxcess Wealth Management LLC grew its holdings in shares of Procter & Gamble by 11.6% during the fourth quarter. Axxcess Wealth Management LLC now owns 115,395 shares of the company’s stock valued at $16,910,000 after purchasing an additional 12,017 shares during the last quarter. U.S. Capital Wealth Advisors LLC raised its position in shares of Procter & Gamble by 6.8% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 77,890 shares of the company’s stock worth $11,414,000 after purchasing an additional 4,927 shares during the period. Finally, Horan Capital Advisors LLC. grew its stake in Procter & Gamble by 5.4% during the 4th quarter. Horan Capital Advisors LLC. now owns 28,030 shares of the company’s stock worth $4,107,000 after buying an additional 1,447 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other news, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the transaction, the insider now owns 11,886 shares in the company, valued at approximately $1,908,891.60. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the sale, the insider now owns 11,886 shares of the company’s stock, valued at $1,908,891.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $162.90, for a total transaction of $5,049,900.00. Following the completion of the transaction, the chief operating officer now directly owns 9,739 shares in the company, valued at approximately $1,586,483.10. The disclosure for this sale can be found here. Insiders sold 86,865 shares of company stock valued at $14,059,180 in the last three months. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG traded up $0.62 during trading hours on Friday, hitting $164.46. 5,581,692 shares of the company were exchanged, compared to its average volume of 6,941,715. The firm has a fifty day simple moving average of $160.01 and a 200-day simple moving average of $154.17. The company has a market capitalization of $388.15 billion, a PE ratio of 26.87, a PEG ratio of 3.34 and a beta of 0.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.71.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm’s revenue was up .6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 earnings per share. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.45%. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent research reports. The Goldman Sachs Group started coverage on Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price on the stock. Jefferies Financial Group upped their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research report on Monday, April 22nd. Deutsche Bank Aktiengesellschaft cut their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, January 18th. Finally, Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $169.76.

View Our Latest Analysis on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.